05/19/2025
4:32 PM | Baynes Roy D. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:32 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:33 PM | Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:32 PM | Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
7:44 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
9:44 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
5:18 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/02/2025
3:22 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2025
6:35 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:35 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:35 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
7:57 PM | BlackRock, Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/08/2025
3:02 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
3:06 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/28/2025
1:06 PM | Nurix Therapeutics (Filer)
| Form DEFA14A | |
03/28/2025
8:03 AM | Nurix Therapeutics (Filer)
| Form ARS | |
03/28/2025
5:03 AM | Nurix Therapeutics (Filer)
| Form DEF 14A | |
03/03/2025
4:29 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:17 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
3:31 PM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/14/2025
7:42 AM | Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
3:12 PM | Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
7:03 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:33 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:48 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:53 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
6:43 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
3:15 PM | Nurix Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:33 PM | ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
4:28 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:20 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
5:54 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:34 AM | FMR LLC (Filed by)
Nurix Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/02/2024
5:00 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
11:48 AM | Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
Man who predicted $100K Bitcoin sees a huge run coming for another coin … (Ad) Sure enough, Bitcoin took off on the exact day Juan said it would.
It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .…
Now Juan believes it could hit $150,000 … or higher in 2025. There's another coin he thinks could do even better. |
11/08/2024
9:52 AM | Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
4:37 PM | MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
4:48 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
4:57 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:50 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:41 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:36 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
10/31/2024
3:12 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:01 PM | Nurix Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:41 PM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:47 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2024
3:48 PM | Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:16 AM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Nurix Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
6:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:32 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
6:01 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:33 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:28 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
5:23 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
4:41 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:24 PM | Nurix Therapeutics (Subject)
Ring Christine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:25 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:31 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
6:06 PM | Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:06 PM | Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:45 PM | Nurix Therapeutics (Filer)
| Form 424B5 | |
07/01/2024
5:35 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
2:23 PM | Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
6:02 AM | Nurix Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:39 PM | Nurix Therapeutics (Issuer)
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
6:30 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
| Form SC 13G/A | |
06/05/2024
5:01 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
5:36 PM | Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy NRIX Stock Free NRIX Stock Alerts